Clinical Prosthetics-Orthotics Kingston, NY - 12401

Clinical Prosthetics-Orthotics is categorized under Medical Labs in Kingston, NY and active since 2002.

Clinical Prosthetics-Orthotics was established in 2002, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 4461990 by the NAICS.

If you are seeking more information, feel free to contact Dennis Ebbing, Owner at the company’s single location by writing to 144 Pine St # 120, Kingston, New York NY 12401 or by phoning (845) 336-7762. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Clinical Prosthetics-Orthotics
Contact Person: Dennis Ebbing, Owner
Address: 144 Pine St # 120, Kingston, New York 12401
Phone Number: (845) 336-7762
Website Address: clinicalpando.com
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 2002
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Medical Labs
SIC Code: 8071
NAICS Code: 4461990
Share This Business:

Clinical Prosthetics-Orthotics was started in 2002 to provide professional Medical Labs under the SIC code 8071 and NAICS code 4461990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Dennis Ebbing, Owner for inquiries that concern Clinical Prosthetics-Orthotics by calling the company number (845) 336-7762, as your correspondence is most welcome. Additionally, the physical location of the single location of Clinical Prosthetics-Orthotics can be found at the coordinates 41.92943,-74.01427 as well as the street address 144 Pine St # 120 in Kingston, New York 12401.

For its online presence, you may visit Clinical Prosthetics-Orthotics’s website at clinicalpando.com and engage with its social media outlets through on Twitter and on Facebook.